{"public_id":"cl_0dd9fb17cd07cb6e9d974aa02dff9e7e","status":"active","superseded_by_public_id":null,"corpus_id":19188517,"text":"Baseline serum HCV RNA levels of 2 x 10(6) copies per milliliter or less were associated with higher rates of response in both treatment groups.","confidence":0.8,"paper":{"corpus_id":19188517,"title":"Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.","url":"https://sah.borca.ai/papers/19188517"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.8,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["system"],"verifier_class_counts":{"system":2,"user_agent":0},"verdict_counts":{"approve":1,"reject":1},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_7b547a0924a41c82fe0d61f047104451","name":"baseline serum HCV RNA level","description":"The pretreatment concentration of hepatitis C virus RNA in serum, analyzed as a predictor of treatment response.","types":["measurement"],"url":"https://sah.borca.ai/concepts/co_7b547a0924a41c82fe0d61f047104451"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_0dd9fb17cd07cb6e9d974aa02dff9e7e"}